±³º¸¹®°í SCHOLAR ½ºÄݶó
ÀÌ ÀÚ·á´Â ±¹°¡Áö½Ä ¿¬°è±â°ü°úÀÇ Çù¾à¿¡ µû¶ó ¹«·á·Î Á¦°øµË´Ï´Ù.
¿ø¹®À» ÀÌ¿ëÇϽñâ À§Çؼ­´Â ¿¬°è±â°üÀÇ Á¤Ã¥À» µû¸£°í ÀÖÀ¸´Ï
±Ã±ÝÇϽŠ»çÇ×Àº ¿¬°è±â°üÀ» ÅëÇØ ¹®ÀÇÇϽñ⠹ٶø´Ï´Ù.
°ð ¿¬°è±â°üÀ¸·Î À̵¿ÇÕ´Ï´Ù
º»¹®³»¿ë ¹Ù·Î°¡±â
Ȩ > ´ëÇÑ»ý¸®ÇÐȸ-´ëÇѾฮÇÐȸ > The Korean Journal of Physiology & Pharmacology
³í¹® Ç¥Áö

Cyclophilin A as a New Therapeutic Target for Hepatitis C Virus- induced Hepatocellular Carcinoma

¿ø¹®º¸±â ¿ø¹®ÀúÀå ÀοëÁ¤º¸º¹»ç ±¸¸Å 4,000¿ø

±¹¹® ÃÊ·Ï

* ÇöÀç ÄÁÅÙÃ÷ Á¤º¸¸¦ Áغñ Áß¿¡ ÀÖ½À´Ï´Ù.

¿µ¹® ÃÊ·Ï

Hepatocellular carcinoma (HCC) related to hepatitis B virus (HBV) and hepatitis C virus (HCV) infections is thought to account for more than 80% of primary liver cancers. Both HBV and HCV can establis...

[´õº¸±â]

¸ñÂ÷

* ÇöÀç ÄÁÅÙÃ÷ Á¤º¸¸¦ Áغñ Áß¿¡ ÀÖ½À´Ï´Ù.